Matthew R. Patterson, Chief Operating Officer at AMICUS THERAPEUTICS INC ([FOLD]), sold 1,900 shares at $11.11 ($21K) on 2008-06-19, disclosed to the SEC on 2008-07-22.
Scheduled sale ($21k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.95 | 100 | $1K | 5.2% |
| 2 | $10.97 | 400 | $4K | 21.0% |
| 3 | $10.99 | 100 | $1K | 5.3% |
| 4 | $11.00 | 400 | $4K | 21.0% |
| 5 | $11.01 | 200 | $2K | 10.5% |
| 6 | $11.02 | 200 |
| $2K |
| 10.5% |
| 7 | $11.12 | 100 | $1K | 5.3% |
| 8 | $11.02 | 86 | $948 | 4.5% |
| 9 | $11.03 | 300 | $3K | 15.8% |
| 10 | $11.11 | 14 | $156 | 0.7% |
| Total | $11.01 avg | 1,900 | $21K | 100% |
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |